AAAAAA

   
Results: 1-14 |
Results: 14
Phase I and pharmacological study of paclitaxel given over 3 h with cisplatin for advanced non-small cell lung cancer
Authors: Kurata, T Tamura, T Shinkai, T Ohe, Y Kunitoh, H Kodama, T Kakinuma, R Matsumoto, T Kubota, K Omatsu, H Nishiwaki, Y Saijo, N
Citation: T. Kurata et al., Phase I and pharmacological study of paclitaxel given over 3 h with cisplatin for advanced non-small cell lung cancer, JPN J CLIN, 31(3), 2001, pp. 93-99
Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients
Authors: Ohe, Y Niho, S Kakinuma, R Kubota, K Matsumoto, T Ohmatsu, H Goto, K Kunitoh, H Saijo, N Nishiwaki, Y
Citation: Y. Ohe et al., Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients, JPN J CLIN, 31(3), 2001, pp. 100-106
A dose escalation study of paclitaxel and carboplatin in untreated Japanese patients with advanced non-small cell lung cancer
Authors: Akiyama, Y Ohe, Y Tamura, T Sawada, M Inoue, A Kusaba, H Yamamoto, N Sekine, I Kunitoh, H Kodama, T Saijo, N
Citation: Y. Akiyama et al., A dose escalation study of paclitaxel and carboplatin in untreated Japanese patients with advanced non-small cell lung cancer, JPN J CLIN, 31(10), 2001, pp. 482-487
Radiation pneumonitis in lung cancer patients: A retrospective study of risk factors and the long-term prognosis
Authors: Inoue, A Kunitoh, H Sekine, I Sumi, M Tokuuye, K Saijo, N
Citation: A. Inoue et al., Radiation pneumonitis in lung cancer patients: A retrospective study of risk factors and the long-term prognosis, INT J RAD O, 49(3), 2001, pp. 649-655
Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: asingle-center experience in Japan
Authors: Kanda, Y Mineishi, S Saito, T Seo, S Saito, A Ohnishi, M Suenaga, K Niiya, H Nakai, K Takeuchi, T Kawahigashi, N Shoji, N Ogasawara, T Tanosaki, R Kobayashi, Y Tobinai, K Kami, M Mori, S Suzuki, R Kunitoh, H Takaue, Y
Citation: Y. Kanda et al., Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: asingle-center experience in Japan, BONE MAR TR, 27(4), 2001, pp. 437-444
A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer
Authors: Kunitoh, H Akiyama, Y Kusaba, H Yamamoto, N Sekine, I Ohe, Y Kubota, K Tamura, T Shinkai, T Kodama, T Goto, K Niho, S Nishiwaki, Y Saijo, N
Citation: H. Kunitoh et al., A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer, LUNG CANC, 33(2-3), 2001, pp. 259-265
New drug and multimodality combinations in the treatment of advanced non-small cell lung cancer
Authors: Kawahara, M Kris, MG Green, M Kunitoh, H
Citation: M. Kawahara et al., New drug and multimodality combinations in the treatment of advanced non-small cell lung cancer, SEMIN ONCOL, 28(3), 2001, pp. 1-4
Correlation between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of exogenous cortisol
Authors: Yamamoto, N Tamura, T Kamiya, Y Sekine, I Kunitoh, H Saijo, N
Citation: N. Yamamoto et al., Correlation between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of exogenous cortisol, J CL ONCOL, 18(11), 2000, pp. 2301-2308
Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma
Authors: Nakamura, Y Kunitoh, H Kubota, K Sekine, I Shinkai, T Tamura, T Kodama, T Sumi, M Kohno, S Saijo, N
Citation: Y. Nakamura et al., Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma, JPN J CLIN, 30(9), 2000, pp. 385-388
Bacterial meningitis observed in a phase I trial of vinorelbine, cisplatinand thoracic radiotherapy for non-small cell lung cancer: Report of a caseand discussion on dose-limiting toxicity
Authors: Sekine, I Matsuda, T Saisho, T Watanabe, H Yamamoto, N Kunitoh, H Ohe, Y Tamura, T Kodama, T Saijo, N
Citation: I. Sekine et al., Bacterial meningitis observed in a phase I trial of vinorelbine, cisplatinand thoracic radiotherapy for non-small cell lung cancer: Report of a caseand discussion on dose-limiting toxicity, JPN J CLIN, 30(9), 2000, pp. 401-405
Phase I study of a weekly infusion of irinotecan hydrochloride (CPT-11) and a 14-day continuous infusion of etoposide in patients with lung cancer: JCOG trial 9408
Authors: Fujishiro, M Shinkai, T Fukuda, M Tamura, T Ohe, Y Kunitoh, H Nishiwaki, Y Sekine, I Fukuda, H Saijo, N
Citation: M. Fujishiro et al., Phase I study of a weekly infusion of irinotecan hydrochloride (CPT-11) and a 14-day continuous infusion of etoposide in patients with lung cancer: JCOG trial 9408, JPN J CLIN, 30(11), 2000, pp. 487-493
Progressive disease rate as a surrogate endpoint of phase II trials for non-small-cell lung cancer
Authors: Sekine, I Tamura, T Kunitoh, H Kubota, K Shinkai, T Kamiya, Y Saijo, N
Citation: I. Sekine et al., Progressive disease rate as a surrogate endpoint of phase II trials for non-small-cell lung cancer, ANN ONCOL, 10(6), 1999, pp. 731-733
Histologic types of lung carcinoma and related family history of anatomic sites and histologic types of cancers
Authors: Kunitoh, H Sekine, I Kubota, K Tamura, T Shinkai, T Kodama, T Saijo, N Naruke, T Yamaguchi, N
Citation: H. Kunitoh et al., Histologic types of lung carcinoma and related family history of anatomic sites and histologic types of cancers, CANCER, 86(7), 1999, pp. 1182-1188
CYP2A6 gene deletion reduces susceptibility to lung cancer
Authors: Miyamoto, M Umetsu, Y Dosaka-Akita, H Sawamura, Y Yokota, J Kunitoh, H Nemoto, N Sato, K Ariyoshi, N Kamataki, T
Citation: M. Miyamoto et al., CYP2A6 gene deletion reduces susceptibility to lung cancer, BIOC BIOP R, 261(3), 1999, pp. 658-660
Risultati: 1-14 |